Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT
Wieczorek, M., Labopin, M., Castagna, L., Brissot, E., Socié, G., Raiola, A. M., Angelucci, E., Rodríguez, A. B., Yakoub‐Agha, I., Aljurf, M., Crawley, C., Mear, J. B., Musso, M., Fanin, R., Avenoso, D., Turlure, P., Tecchio, C., Sanz, J., Ciceri, F., … Mohty, M. (2022). Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT. En American Journal of Hematology (Vol. 98, Issue 2). Wiley. https://doi.org/10.1002/ajh.26782
Wiley
